NECi offers enzymes and enzyme-based test kits for the analysis of nitrate and phosphate in the laboratory or out in the field.
BMG LABTECH, a manufacturer of microplate readers, recently received a patent for its dual monochromator technology using Linear Variable Filters (LVF). The technology offers flexibility and sensitivity for fluorescence and luminescence applications.
Cyclic adenosine monophosphate (cAMP) is an intracellular signalling molecule that is a key mediator in a variety of pathways, including glycogen metabolism, gene regulation and olfactory sensory transduction.
Illumina has announced the Nextera DNA Flex Library Prep Kit for whole genome sequencing. It eliminates the need for sample preparation for whole blood and saliva and removes tedious steps in the library prep workflow, such as mechanical fragmentation of DNA, quantification and normalisation.
The genetic identification services Eurofins | ams provides allow for the identification and characterisation of bacterial, yeast and mould isolates to the species level.
According to a new study from UNSW, antimicrobial resistance (AMR) is not itself an epidemic. Rather, it has the potential to worsen pandemics or seasonal influenza epidemics, and should be kept in perspective.
CHROMagar Y.enterocolitica for detection and differentiation of pathogenic Yersinia enterocolitica strains18 September, 2017 | Supplied by: Dutec Diagnostics Pty Ltd
CHROMagar has launched an updated version of CHROMagar Y.enterocolitica, with improved selectivity and sensitivity. Pathogenic strains are immediately differentiated from non-pathogenic Yersinia enterocolitica and other bacteria by a distinctive mauve colony colour.
Scientists have developed a new system to identify and characterise the molecular components that control the activities of regulatory DNA sequences in the human genome.
QIAGEN has announced the implementation of the PAXgene Blood ccfDNA Tube with Clinical Genomics' Colvera colorectal cancer (CRC) recurrence assay, enabling blood to be drawn and stored for several days before testing.
US scientists have used CRISPR to edit human embryos, removing a mutation linked to a heritable heart condition.